These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35096881)

  • 1. Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer.
    Zhang Z; Xu Z; Yan Y
    Front Med (Lausanne); 2021; 8():793515. PubMed ID: 35096881
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma.
    Zhang Z; Xia F; Xu Z; Peng J; Kang F; Li J; Zhang W; Hong Q
    Sci Rep; 2022 May; 12(1):8886. PubMed ID: 35614201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of an Exosomes-Related lncRNAs Signature in Tumor Immune Microenvironment of Gastric Cancer.
    Li C; Zhang Z; Peng E; Peng J
    Front Cell Dev Biol; 2022; 10():873319. PubMed ID: 35465325
    [No Abstract]   [Full Text] [Related]  

  • 4. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
    Ping L; Zhang K; Ou X; Qiu X; Xiao X
    Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
    [No Abstract]   [Full Text] [Related]  

  • 5. Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer.
    Cao X; Zhang Q; Zhu Y; Huo X; Bao J; Su M
    Front Oncol; 2022; 12():780950. PubMed ID: 35280739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
    Front Genet; 2022; 13():838624. PubMed ID: 35928454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pyroptosis-related lncRNA signature in bladder cancer.
    Wang P; Wang Z; Zhu L; Sun Y; Castellano L; Stebbing J; Yu Z; Peng L
    Cancer Med; 2023 Mar; 12(5):6348-6364. PubMed ID: 36237132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic exosome-related LncRNA risk model correlates with the immune microenvironment in liver cancer.
    Su D; Zhang Z; Xu Z; Xia F; Yan Y
    Front Genet; 2022; 13():965329. PubMed ID: 36081999
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.
    Zhou W; Zhang W
    BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer.
    Pan X; Bi F
    Front Genet; 2021; 12():694009. PubMed ID: 34367253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell death-related lncRNA signature as a predictive factor of clinical outcomes and immune checkpoints in gastric cancer.
    Zhang Z; Su D; Thakur A; Zhang K; Xia F; Yan Y
    Front Pharmacol; 2023; 14():1162995. PubMed ID: 37081965
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.
    Liu ZK; Wu KF; Zhang RY; Kong LM; Shang RZ; Lv JJ; Li C; Lu M; Yong YL; Zhang C; Zheng NS; Li YH; Chen ZN; Bian H; Wei D
    Front Oncol; 2022; 12():794034. PubMed ID: 35311105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a PANoptosis-related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Ovarian Cancer.
    Liu Y; Lyu G
    Curr Med Chem; 2024 Sep; ():. PubMed ID: 39248067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
    Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
    J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer.
    Xu H; Lu M; Liu Y; Ren F; Zhu L
    J Cancer; 2023; 14(16):3151-3168. PubMed ID: 37859811
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction of prognostic signature of patients with oral squamous cell carcinoma based on pyroptosis-related long non-coding RNAs.
    Xin Y; Zhang J; Jiang Q; Qiu J
    Front Surg; 2022; 9():935765. PubMed ID: 36211292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of Pyroptosis-Related lncRNA Signature and Its Correlation with Immune Landscape in Soft Tissue Sarcomas.
    Lin Z; Xu Y; Zhang X; Wan J; Zheng T; Chen H; Chen S; Liu T
    Int J Gen Med; 2021; 14():8263-8279. PubMed ID: 34815699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma.
    Xing Z; Liu Z; Fu X; Zhou S; Liu L; Dang Q; Guo C; Ge X; Lu T; Zheng Y; Dai L; Han X; Wang X
    Front Cell Dev Biol; 2022; 10():805291. PubMed ID: 35223836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.